Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Noriega

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Infectious Diseases|November 1, 1993
Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian childrenC H Simanjuntak, P O'Hanley, N H Punjabi, et al.
Lupus|September 1, 2017
Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature reviewM L Vieira, E R M C Marques, Y L A Leda, et al.
Infection and Immunity|December 1, 1995
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strainsJ P Nataro, J Seriwatana, A Fasano, et al.
Vaccine: X|July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.
Vaccine: X|April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.
Vaccine: X|September 27, 2022
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled studyS Mangarule, S Prashanth, A Kawade, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2018
Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin AmericaJ L Arredondo-García, S R Hadinegoro, H Reynales, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Infectious Diseases|November 1, 1993
Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian childrenC H Simanjuntak, P O'Hanley, N H Punjabi, et al.
Lupus|September 1, 2017
Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature reviewM L Vieira, E R M C Marques, Y L A Leda, et al.
Infection and Immunity|December 1, 1995
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strainsJ P Nataro, J Seriwatana, A Fasano, et al.
Vaccine: X|July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.
Vaccine: X|April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.
Vaccine: X|September 27, 2022
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled studyS Mangarule, S Prashanth, A Kawade, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2018
Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin AmericaJ L Arredondo-García, S R Hadinegoro, H Reynales, et al.
Pageof 3